Group 5A: ER+ Breast Cancer—Metastatic, ESR1 Mutation

Friday, June 10
2:00 pm – 3:30 pm Eastern Time (US/New York)

Mentor: Lianne Kraemer

Lianne Kraemer received both her Bachelor of Health Science and Master of Science degrees from the University of Kentucky. She worked as a Pediatric Speech Language Pathologist specializing in feeding, swallowing and communication disorders in infants, toddlers and young children with neuromotor impairments. At 37 years old Lianne was diagnosed with stage 2 breast cancer. Despite receiving aggressive treatment, her cancer quickly returned as stage IV MBC. Lianne’s initial metastatic diagnosis was that of brain metastases only. She has never presented with disease outside the CNS.

Knowing there is no cure for MBC, Lianne became an outspoken advocate for increased funding for MBC research. She is the co-founder of the Chicago Metsquerade, a gala benefiting METAvivor. Her fundraising has raised over $400,000 for MBC focused research. Her work in advocacy has led to two features in TIME Magazine, speaking engagements on conference panels and pharmacy company meetings, and requests to review research grants. Lianne serves as a patient advocate for the Dana Farber Cancer Institute. Lianne also served as patient advocate on the task force that developed the ASTRO Clinical Practice Guideline on Radiation Therapy for Brain Mets. Lianne is a member of MBC Alliance’s Breast Cancer Brain Metastasis (BCBM) Initiative: Marina Kaplan Project to address research needs of breast cancer patients living with CNS metastasis. Lianne is one of the founders of the website, a resource for patients with breast cancer CNS metastasis.

Twitter: @lianne_kraemer

Scientist: Erika Hamilton, M.D.

Erika P Hamilton, M.D., cares for patients with breast and gynecologic cancer. As the director of the breast cancer and gynecologic cancer research program at Sarah Cannon Research Institute, she oversees the program and the clinical trial menu for these cancers across the Sarah Cannon network. After receiving an undergraduate degree from Washington and Lee University in Virginia, Dr. Hamilton completed her medical degree and residency from the University of North Carolina in Chapel Hill. She received her fellowship training in hematology and oncology from Duke University in Durham, North Carolina, where she was recognized as a Top 5 Finalist for Duke’s Annual House staff Fellow Teaching Award. She is board certified in internal medicine and oncology. Additionally, she is a partner with Tennessee Oncology, PLLC.

Twitter: @ErikaHamilton9